(Q36644653)

15 August 2017

Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma (English)

1 reference

15 August 2017

G Sanguineti

1

1 reference

15 August 2017

S Agostinelli

2

1 reference

15 August 2017

F Foppiano

3

1 reference

15 August 2017

P Franzone

4

1 reference

15 August 2017

S Garelli

5

1 reference

15 August 2017

M Marcenaro

6

1 reference

15 August 2017

M Orsatti

7

1 reference

15 August 2017

V Vitale

8

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

86

1 reference

15 August 2017

12

1 reference

15 August 2017

1843-1847

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600266

15 August 2017

0 references

cites work

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375428

Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375428

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375428

Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375428

Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375428

Clinical symptoms and comorbidity: significance for the prognostic classification of cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375428

Late effects of radiation therapy on the gastrointestinal tract

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375428

Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy

30 September 2017

1 reference

12 December 2020

Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer

1 reference

12 December 2020

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

12 December 2020

Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study

1 reference

12 December 2020

Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

1 reference

12 December 2020

Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/N0, M0) adenocarcinoma of the prostate

1 reference

12 December 2020

Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response

1 reference

12 December 2020

Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer

1 reference

12 December 2020

Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: long-term results of a prospective randomized study

1 reference

12 December 2020

Bowel complications after radiotherapy for carcinoma of the prostate: the volume effect

1 reference

12 December 2020

Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma

1 reference

12 December 2020

Neoadjuvant hormonal downsizing of localized carcinoma of the prostate: effects on the volume of normal tissue irradiation

1 reference

12 December 2020

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

12 December 2020

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

12 December 2020

Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer

1 reference

12 December 2020

Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate

1 reference

12 December 2020

Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6600266

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

12085173

1 reference